Association between progression-free survival and metal stent patency in patients with advanced pancreatic cancer.

Journal of gastrointestinal oncology(2022)

引用 0|浏览5
暂无评分
摘要
SEMS patency may be associated with PFS in patients with advanced pancreatic cancer who receive GnP or FOLFIRINOX.
更多
查看译文
关键词
Pancreatic cancer,progression-free survival,self-expandable metallic stent
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要